Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,922 USD | -4,21% | -6,06% | -58,38% |
Omzet 2024 * | 600K 561K | Omzet 2025 * | 600K 561K | Marktkapitalisatie | 7,36 mln. 6,88 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -23 mln. -21,51 mln. | Nettowinst (verlies) 2025 * | -31 mln. -28,99 mln. | EV/omzet 2024 * | 12,3 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 12,3 x |
K/w-verhouding 2024 * |
-0,4
x | K/w-verhouding 2025 * |
-0,39
x | Werknemers | 19 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 94,12% |
Recentste transcriptie over TFF Pharmaceuticals, Inc.
1 dag | -4,21% | ||
1 week | -6,06% | ||
Lopende maand | -51,63% | ||
1 maand | -54,98% | ||
3 maanden | -41,94% | ||
6 maanden | -62,91% | ||
Lopend jaar | -58,38% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harlan Weisman
CEO | Chief Executive Officer | 71 | 01-12-18 |
Kirk Coleman
DFI | Director of Finance/CFO | 51 | 24-01-18 |
Zamaneh Mikhak
CTO | Chief Tech/Sci/R&D Officer | 59 | 09-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 52 | 01-12-18 | |
Brandi Roberts
BRD | Director/Board Member | 50 | 25-03-22 |
Thomas King
BRD | Director/Board Member | 69 | 13/12 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 2,922 | -4,21% | 34 088 |
25-04-24 | 3,05 | +1,33% | 19 364 |
24-04-24 | 3,01 | +1,35% | 12 712 |
23-04-24 | 2,97 | +15,12% | 62 771 |
22-04-24 | 2,58 | -17,04% | 47 266 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-58,38% | 7,36 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |